New Drug Development and Drug Approvals Developed by market Players Drives the Global Fampridine Market

The global fampridine market is expected to grow at a significant rate during the forecast (2022-2028). The key companies operating in the industry are highly inclined to adopt numerous growth strategies including partnerships collaborations, mergers and acquisitions, geographical expansion, and new product introductions to fulfill the growing market demands that is the key factor driving the market growth For instance, in December 2018, Hikma Pharmaceuticals USA Inc., formerly known as West-Ward Pharmaceuticals Corp., launched Dalfampridine Extended-release Tablets, 10 mg, the generic pharmaceutical equivalent to Ampyra, according to Hikma Pharmaceuticals PLC. Apart from these, the significant approvals to drug developed by market players is further helping in the market growth. Such as,  in May 2021, Bojian Company announced that Fampridine Sustained-Release Tablets had been approved by China's National Medical Products Administration for the treatment of multiple sclerosis (MS) in adult patients with a walking disorder. Fampridine sustained-release pills are the first medication in China to improve the walking capacity of adult MS patients. Fampridine sustained-release pills are among the first batch of clinically urgently needed international new medications. The findings revealed that patients who were given fampridine sustained-release pills walked much faster than those who were given a placebo.

Browse the full report of " The Global Fampridine Market Size, Share, and Trends by Type (Purity: 95%) Purity (>95%), by Form (Generic and Branded), and Forecast (2022-2028)" at https://www.omrglobal.com/industry-reports/fampridine-market

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By type
• By form 

Regions Covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape- including Tiefenbacher, Clearsynth, Jubilant Pharma, Teva, Kunshan Zhendong Chemical and others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity? 

Global Fampridine Market Report Segment

By type

• Purity: 95%
• Purity: >95%

By form

• Branded
• Generic

Global Fampridine Market Growth, by Region

North America

• US
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa